| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $124.7M | +46.5% | -3.9% |
| Cost of Revenue | $94.3M | +49.7% | -0.9% |
| Gross Profit | $30.3M | +37.5% | -12.1% |
| R&D Expense | $2.4M | -19.1% | +9.5% |
| SG&A Expense | $13.5M | +1.1% | -14.7% |
| Operating Income | $4.1M | +239.1% | -41.0% |
| Pre-tax Income | $3.0M | +173.3% | -45.8% |
| Income Tax | $1.1M | +258.0% | -22.9% |
| Net Income | $1.9M | +156.2% | -53.6% |
| EPS (Basic) | $0.04 | +150.0% | -55.6% |
| EPS (Diluted) | $0.04 | +150.0% | -55.6% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.4M | +24.9% | -42.6% |
| Accounts Receivable | $45.8M | +11.0% | -13.0% |
| Current Assets | $268.5M | -2.5% | -12.3% |
| Total Assets | $548.6M | -1.1% | -6.6% |
| Current Liabilities | $53.9M | +1.9% | -30.2% |
| Total Liabilities | $185.4M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $19.2M | +336.2% | — |
| Capital Expenditures | $15.3M | +256.1% | — |
| Investing Cash Flow | -$19.9M | -166.1% | — |
| Financing Cash Flow | -$2.1M | -125.3% | — |
| Free Cash Flow | $3.9M | +131.3% | — |
| -15.1% |
| Stockholders' Equity | $363.2M | -0.3% | -1.6% |